Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

The proteasomal inhibitor MG132 prevents muscular dystrophy in zebrafish.

Winder SJ, Lipscomb L, Angela Parkin C, Juusola M.

PLoS Curr. 2011 Nov 17;3:RRN1286. doi: 10.1371/currents.RRN1286.

2.

Drug screening in a zebrafish model of Duchenne muscular dystrophy.

Kawahara G, Karpf JA, Myers JA, Alexander MS, Guyon JR, Kunkel LM.

Proc Natl Acad Sci U S A. 2011 Mar 29;108(13):5331-6. doi: 10.1073/pnas.1102116108. Epub 2011 Mar 14.

3.

The HDAC Inhibitor TSA Ameliorates a Zebrafish Model of Duchenne Muscular Dystrophy.

Johnson NM, Farr GH 3rd, Maves L.

PLoS Curr. 2013 Sep 17;5. pii: ecurrents.md.8273cf41db10e2d15dd3ab827cb4b027. doi: 10.1371/currents.md.8273cf41db10e2d15dd3ab827cb4b027.

4.

Identification of a zebrafish model of muscular dystrophy.

Bassett D, Currie PD.

Clin Exp Pharmacol Physiol. 2004 Aug;31(8):537-40.

PMID:
15298547
5.

Dystrophin is required for the formation of stable muscle attachments in the zebrafish embryo.

Bassett DI, Bryson-Richardson RJ, Daggett DF, Gautier P, Keenan DG, Currie PD.

Development. 2003 Dec;130(23):5851-60.

6.

Muscle dysfunction in a zebrafish model of Duchenne muscular dystrophy.

Widrick JJ, Alexander M, Sanchez B, Gibbs D, Kawahara G, Beggs A, Kunkel L.

Physiol Genomics. 2016 Oct 7:physiolgenomics.00088.2016. doi: 10.1152/physiolgenomics.00088.2016. [Epub ahead of print]

PMID:
27764767
7.

Muscle dysfunction and structural defects of dystrophin-null sapje mutant zebrafish larvae are rescued by ataluren treatment.

Li M, Andersson-Lendahl M, Sejersen T, Arner A.

FASEB J. 2014 Apr;28(4):1593-9. doi: 10.1096/fj.13-240044. Epub 2013 Dec 26.

8.

Quantification of birefringence readily measures the level of muscle damage in zebrafish.

Berger J, Sztal T, Currie PD.

Biochem Biophys Res Commun. 2012 Jul 13;423(4):785-8. doi: 10.1016/j.bbrc.2012.06.040. Epub 2012 Jun 16.

PMID:
22713473
9.

Histological parameters for the quantitative assessment of muscular dystrophy in the mdx-mouse.

Briguet A, Courdier-Fruh I, Foster M, Meier T, Magyar JP.

Neuromuscul Disord. 2004 Oct;14(10):675-82.

PMID:
15351425
10.

Preventing phosphorylation of dystroglycan ameliorates the dystrophic phenotype in mdx mouse.

Miller G, Moore CJ, Terry R, La Riviere T, Mitchell A, Piggott R, Dear TN, Wells DJ, Winder SJ.

Hum Mol Genet. 2012 Oct 15;21(20):4508-20. Epub 2012 Jul 18.

PMID:
22810924
11.

Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice.

Burkin DJ, Wallace GQ, Nicol KJ, Kaufman DJ, Kaufman SJ.

J Cell Biol. 2001 Mar 19;152(6):1207-18.

12.
13.

Genetic isolation and characterization of a splicing mutant of zebrafish dystrophin.

Guyon JR, Goswami J, Jun SJ, Thorne M, Howell M, Pusack T, Kawahara G, Steffen LS, Galdzicki M, Kunkel LM.

Hum Mol Genet. 2009 Jan 1;18(1):202-11. doi: 10.1093/hmg/ddn337. Epub 2008 Oct 28.

14.

Animal models for muscular dystrophy show different patterns of sarcolemmal disruption.

Straub V, Rafael JA, Chamberlain JS, Campbell KP.

J Cell Biol. 1997 Oct 20;139(2):375-85.

15.

Diagnosis and cell-based therapy for Duchenne muscular dystrophy in humans, mice, and zebrafish.

Kunkel LM, Bachrach E, Bennett RR, Guyon J, Steffen L.

J Hum Genet. 2006;51(5):397-406. Epub 2006 Apr 1. Review.

16.

Quantitative assessment of muscle damage in the mdx mouse model of Duchenne muscular dystrophy using polarization-sensitive optical coherence tomography.

Yang X, Chin L, Klyen BR, Shavlakadze T, McLaughlin RA, Grounds MD, Sampson DD.

J Appl Physiol (1985). 2013 Nov 1;115(9):1393-401. doi: 10.1152/japplphysiol.00265.2013. Epub 2013 Aug 29.

17.

A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice.

Wehling M, Spencer MJ, Tidball JG.

J Cell Biol. 2001 Oct 1;155(1):123-31.

18.

[Muscle regeneration in mdx mouse, and a trial of normal myoblast transfer into regenerating dystrophic muscle].

Takemitsu M, Arahata K, Nonaka I.

Rinsho Shinkeigaku. 1990 Oct;30(10):1066-72. Japanese.

PMID:
2279357
19.

Pharmacological control of cellular calcium handling in dystrophic skeletal muscle.

Ruegg UT, Nicolas-Métral V, Challet C, Bernard-Hélary K, Dorchies OM, Wagner S, Buetler TM.

Neuromuscul Disord. 2002 Oct;12 Suppl 1:S155-61. Review.

PMID:
12206810
20.

Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity.

Cox GA, Cole NM, Matsumura K, Phelps SF, Hauschka SD, Campbell KP, Faulkner JA, Chamberlain JS.

Nature. 1993 Aug 19;364(6439):725-9.

Supplemental Content

Support Center